Market Overview

Leerink Swann Initiates Coverage on GW Pharma at Outperform, Announces $79 Price Target

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GWPH

DateFirmActionFromTo
Dec 2017Goldman SachsUpgradesNeutralBuy
Nov 2017Bank of AmericaMaintainsBuy
Oct 2017Leerink SwannMaintainsOutperform

View More Analyst Ratings for GWPH
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (GWPH)